Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-214-4 | CAS number: 21109-95-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 1983
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP-compliant guideline study with the following deviations: - According to the guideline, healthy young adults should be used. The age of the rats was missing in this report. - The analytical purity of the test substance is not indicated in the report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Barium sulphide
- EC Number:
- 244-214-4
- EC Name:
- Barium sulphide
- Cas Number:
- 21109-95-5
- Molecular formula:
- BaS
- IUPAC Name:
- barium(2+) sulfanediide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): barium sulfide
- Analytical purity: not stated in the report. But based on information from the study sponsor it can be assumed that the purity of the test substance is 75%.
- pH of suspensions: ca. 13
- appearance: dark grey powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. A. Ivanovas, 7964 Kisslegg/Allgäu
- Age at study initiation: Not reported
- Weight at study initiation: Males: 95-125 g; Females: 90-120 g
- Housing: Group housing of five animals per sex per cage in labelled Makrolon cages (type III) containing sawdust bedding material (Fa. Brandenburg, 2849 Goldenstedt-Arkeburg).
- Diet (ad libitum except overnight prior to and approx. 4 hours after dosing): Pelleted rodent diet (Ssniff R10 pellets, Ssniff Versuchstierdiäten, 4770 Soest/Westf.
- Water (ad libitum): Tap water
- Acclimation period: 5 days before start of treatment
ENVIRONMENTAL CONDITIONS
Animals were housed in a controlled environment.
- Temperature: ca. 20°C
- Relative humidity: 40 - 60 %
- Air changes: Approx. 10 air changes per hour
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 1%
MAXIMUM DOSE VOLUME APPLIED: 5.0 ml/kg
The control animals received the vehicle alone. - Doses:
- 215 mg/kg, 261 mg/kg, 316 mg/kg, 383 mg/kg
- No. of animals per sex per dose:
- 5 male / 5 female
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: On the day of dosing animals were observed for signs of reaction to treatment at frequent intervals. On subsequent days animals were observed at leaste once daily. Individual bodyweights were recorded on the day of dosing and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/
Please refer to the attachement
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 275 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 210 - 361
- Remarks on result:
- other: R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 336 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 321 - 351
- Remarks on result:
- other: R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 307 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 275 - 343
- Remarks on result:
- other: R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/
- Mortality:
- Number of dead males per dose:
Control: 0/5
215 mg/kg: 0/5
261 mg/kg: 0/5
316 mg/kg: 2/5 (within 4 hours after dosing)
383 mg/kg: 4/5 (within 4 hours after dosing)
Number of dead females per dose:
Control: 0/5
215 mg/kg: 0/5
261 mg/kg: 4/5 (within 4 hours after dosing)
316 mg/kg: 3/5 (within 4 hours after dosing)
383 mg/kg: 4/5 (within 4 hours after dosing) - Clinical signs:
- other: Pilo-erection and hunched posture was observed in the control animals on the day of dosing. Clinical signs observed within the first three days in rats treated with barium sulfide included pilo-erection, hunched posture, pallor of extremities, decreased m
- Gross pathology:
- Autopsy mainly revealed congestion of liver and spleen and red colouration, haemorrhaging and congestion of the gastric mucosa in rats that died during the study.
- Other findings:
- The observations by autopsy in rats died during the study (at doses of 261, 316 and 383 mg/kg bw) were as follows: congestion of liver, congestion of spleen, red coloration of the glandular mucous membrane of the stomach, red colored contents in ileum or milky white ileum contents, mucous membrane of the stomach congested and/or hemorrhaged.
Applicant's summary and conclusion
- Interpretation of results:
- toxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- An LD50 of 307 mg/kg bw has been calculated for males/females for barium sulfide. The LD50 for males is 336 mg/kg bw and for females an LD50 of 275 mg/kg bw. has been calculated (see attachment to this robust study summary).
According to Regulation (EC) 1272/2008 the most sensitive species should be chosen for the purposes of the Chemical Safety Assessment. Since data is available for males and females, and females are more sensitive than males, the LD50 value for females was used for classification.
According to the test result the substance has to be classified as toxic if swallowed (H301) due to the fact that mortality was observed at dose levels of < 300 mg/kg bw (LD50 female: 275 mg/kg bw). - Executive summary:
According to 67/548/EEC barium sulfide has to be classified as harmful if swallowed (LD50 >200 and < 2000 mg/kg bw) and labeled with Xn; R22.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.